BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27481247)

  • 1. Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.
    Hortua Triana MA; Cajiao Herrera D; Zimmermann BH; Fox BA; Bzik DJ
    Infect Immun; 2016 Oct; 84(10):2974-81. PubMed ID: 27481247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
    Hegewald J; Gross U; Bohne W
    Mol Biochem Parasitol; 2013 Jul; 190(1):6-15. PubMed ID: 23747278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii.
    Hortua Triana MA; Huynh MH; Garavito MF; Fox BA; Bzik DJ; Carruthers VB; Löffler M; Zimmermann BH
    Mol Biochem Parasitol; 2012 Aug; 184(2):71-81. PubMed ID: 22580100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
    Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M
    Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.
    Fox BA; Bzik DJ
    Nature; 2002 Feb; 415(6874):926-9. PubMed ID: 11859373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
    Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
    Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
    He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
    Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific distribution of dihydroorotate dehydrogenase in the rat central nervous system points to pyrimidine de novo synthesis in neurons.
    Schaefer ChM; Schäfer MK; Löfflerr M
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):476-81. PubMed ID: 20544541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain.
    Löffler M; Carrey EA; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1281-1305. PubMed ID: 32043431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.
    Bajzikova M; Kovarova J; Coelho AR; Boukalova S; Oh S; Rohlenova K; Svec D; Hubackova S; Endaya B; Judasova K; Bezawork-Geleta A; Kluckova K; Chatre L; Zobalova R; Novakova A; Vanova K; Ezrova Z; Maghzal GJ; Magalhaes Novais S; Olsinova M; Krobova L; An YJ; Davidova E; Nahacka Z; Sobol M; Cunha-Oliveira T; Sandoval-Acuña C; Strnad H; Zhang T; Huynh T; Serafim TL; Hozak P; Sardao VA; Koopman WJH; Ricchetti M; Oliveira PJ; Kolar F; Kubista M; Truksa J; Dvorakova-Hortova K; Pacak K; Gurlich R; Stocker R; Zhou Y; Berridge MV; Park S; Dong L; Rohlena J; Neuzil J
    Cell Metab; 2019 Feb; 29(2):399-416.e10. PubMed ID: 30449682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides.
    Löffler M; Jöckel J; Schuster G; Becker C
    Mol Cell Biochem; 1997 Sep; 174(1-2):125-9. PubMed ID: 9309676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.
    Boschi D; Pippione AC; Sainas S; Lolli ML
    Eur J Med Chem; 2019 Dec; 183():111681. PubMed ID: 31557612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition.
    Mathur D; Stratikopoulos E; Ozturk S; Steinbach N; Pegno S; Schoenfeld S; Yong R; Murty VV; Asara JM; Cantley LC; Parsons R
    Cancer Discov; 2017 Apr; 7(4):380-390. PubMed ID: 28255082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction.
    Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Takazaki S; Yamaza H; Nonaka K; Kang D
    Biosci Rep; 2013 Feb; 33(2):e00021. PubMed ID: 23216091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
    Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
    PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase.
    Rawls J; Knecht W; Diekert K; Lill R; Löffler M
    Eur J Biochem; 2000 Apr; 267(7):2079-87. PubMed ID: 10727948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pyrimidine formation in Pseudomonas oryzihabitans.
    West TP
    J Basic Microbiol; 2007 Oct; 47(5):440-3. PubMed ID: 17910097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.
    Fox BA; Bzik DJ
    Infect Immun; 2010 Sep; 78(9):3744-52. PubMed ID: 20605980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
    Singh A; Maqbool M; Mobashir M; Hoda N
    Eur J Med Chem; 2017 Jan; 125():640-651. PubMed ID: 27721149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.